Trexquant Investment’s Immunocore IMCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$5.18M Buy
170,879
+98,033
+135% +$3.33M 0.03% 766
2026
Q2
$2.31M Buy
72,846
+52,161
+252% +$1.54M 0.01% 1134
2026
Q1
$624K Buy
+20,685
New +$669K ﹤0.01% 1398
2025
Q4
– Sell
-100,580
Closed -$3.65M – 1746
2025
Q3
$3.65M Buy
100,580
+81,291
+421% +$2.76M 0.04% 669
2025
Q2
$605K Buy
+19,289
New +$599K 0.01% 1212
2024
Q1
– Sell
-28,545
Closed -$1.95M – 1589
2023
Q4
$1.95M Buy
28,545
+1,746
+7% +$90.8K 0.04% 558
2023
Q3
$1.39M Buy
26,799
+18,768
+234% +$1.11M 0.03% 625
2023
Q2
$482K Sell
8,031
-29,213
-78% -$1.67M 0.01% 1020
2023
Q1
$1.84M Buy
37,244
+20,992
+129% +$1.18M 0.05% 488
2022
Q4
$928K Buy
+16,252
New +$915K 0.03% 673

Other funds holding IMCR

Trexquant Investment's IMCR Position: Q3 2026 in Review

Trexquant Investment increased its Immunocore (IMCR) stake by 135% in Q3 2026, buying an estimated $3.33M and bringing the position to 170,879 shares worth $5.18M. The position accounts for 0.03% of the portfolio, ranked #766.

Trexquant Investment first reported a position in IMCR in Q4 2022 and has held it in 10 quarters since. 130 funds tracked by Wall St. Rank hold IMCR as of Q3 2026.

  • Trexquant Investment held 170,879 shares of Immunocore worth $5.18M as of Q3 2026.
  • Trexquant Investment bought 98,033 Immunocore shares in Q3 2026, an estimated $3.33M.
  • Immunocore made up 0.03% of Trexquant Investment's portfolio in Q3 2026, its #766 holding.
  • Trexquant Investment first reported a position in Immunocore in Q4 2022 and has held it in 10 quarters since.
  • 130 funds tracked by Wall St. Rank held Immunocore as of Q3 2026.

Based on Trexquant Investment's 13F filing for Q3 2026, filed 16 Nov 2026.